Harano Masahiko, Eto Masatoshi, Yokomizo Akira, Tatsugami Katsunori, Hamaguchi Masumitsu, Naito Seiji
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Fukuoka Igaku Zasshi. 2007 Nov;98(11):389-96.
A laparoscopic radical nephrectomy (LRN) for renal cancer can be performed using two methods, hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS). This institute initially used HALS to perform all radical nephrectomy, but gradually shifted to SLS. This study compared the two methods of radical nephrectomy: HALS vs. SLS, which were performed at a single institute. From March 1999 to November 2006, a total 129 patients with pathologically confirmed renal cell carcinoma underwent LRN, including 73 patients with the HALS and 56 patients with SLS. The median operative time was 264 minutes, and median estimated blood loss was 200 ml in the HALS group, respectively. The median operative time and median estimated blood loss in the SLS were 215 minutes and 100 ml, respectively. There was no significant difference in either the operative time or estimated blood loss between HALS and SLS. The median time to both postoperative oral intake and ambulation in the SLS were 1 day. Neither of these events after SLS was significantly shorter than that after HALS. The 4-year disease-free and overall survival rates in the HALS patients were 97.5% and 98.2%, respectively. Both the 4-year disease-free and overall survival rates in the SLS patients were 100%. Since no significant differences were observed between the two operative methods (SLS and HALS) regarding the operative data, postoperative course and oncological outcome, the surgical method for LRN can be selected according to characteristics of each surgical method.
肾癌的腹腔镜根治性肾切除术(LRN)可采用两种方法进行,即手辅助腹腔镜手术(HALS)和标准腹腔镜手术(SLS)。该机构最初使用HALS进行所有根治性肾切除术,但逐渐转向SLS。本研究比较了在单一机构进行的两种根治性肾切除术方法:HALS与SLS。从1999年3月至2006年11月,共有129例经病理证实为肾细胞癌的患者接受了LRN,其中73例采用HALS,56例采用SLS。HALS组的中位手术时间为264分钟,中位估计失血量为200毫升。SLS组的中位手术时间和中位估计失血量分别为215分钟和100毫升。HALS和SLS在手术时间或估计失血量方面均无显著差异。SLS术后口服摄入和下床活动的中位时间均为1天。SLS术后这两项指标均不比HALS术后明显缩短。HALS患者的4年无病生存率和总生存率分别为97.5%和98.2%。SLS患者的4年无病生存率和总生存率均为100%。由于在手术数据、术后病程和肿瘤学结果方面,两种手术方法(SLS和HALS)未观察到显著差异,因此LRN的手术方法可根据每种手术方法的特点进行选择。